Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Hormone replacement therapy for post-menopausal women may benefit the eyes as well as preventing brittle bones, researchers said yesterday. A study in Spain found a reduced incidence of lens opacity, a precursor of age-related cataract, in post-menopausal women taking oestrogen.
Cataracts, which cause cloudiness and hardening of the lens of the eye, are a leading cause of blindness and affect 90 per cent of people aged over 75. Scientists have long suspected that female hormones may play a role in the development of age-related cataracts, since more women suffer from them than men.
Scientists from the Ramon Castroviejo Institute in Madrid examined the eyes of 19 post-menopausal women taking oestrogen, 23 post-menopausal women not taking oestrogen, and 23 men.
The researchers, whose findings were published in the American journal Ophthalmology, found that the women taking oestrogen had significantly less lens opacity compared with the other groups.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments